Filing search / Ownership / CRISPR Therapeutics AG / Page 7

8-K

lqr0j

12 Feb 20

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

4:05pm

8-K

t8aj5knsv

29 Jan 20

Departure of Directors or Certain Officers

4:16pm

8-K

dxwiomm d4a

27 Dec 19

Termination of a Material Definitive Agreement

4:06pm

8-K

jw8luw 091

16 Dec 19

Entry into a Material Definitive Agreement

7:01am

8-K

qr2ploivyd 3eym

22 Nov 19

Crispr Therapeutics Announces Proposed Public Offering of Common Shares

4:02pm

424B5

n3j3a7dqphs65gm5v5

21 Nov 19

Prospectus supplement for primary offering

4:12pm

424B5

gxnrl4xb9cxvu77

19 Nov 19

Prospectus supplement for primary offering

4:27pm

8-K

3yamfk

19 Nov 19

Regulation FD Disclosure

8:21am

8-K

m7999v22s

28 Oct 19

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results

7:05am

8-K

ncrkiay0x5gs

30 Aug 19

Entry into a Material Definitive Agreement

4:10pm

424B5

hx2t4zeaddhjk2mx

30 Aug 19

Prospectus supplement for primary offering

4:08pm

S-8

ay2s4n

29 Jul 19

Registration of securities for employees

4:32pm

8-K

1430sj ldr

29 Jul 19

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results

4:05pm

8-K

k5u85n4u9c4ojqe7in4f

26 Jun 19

Other Events

8:45am

8-K

kwnane5wo1rlqzz9m

13 Jun 19

Departure of Directors or Certain Officers

4:44pm

8-K

nihdxj3

6 Jun 19

Entry into a Material Definitive Agreement

5:20pm

DEFA14A

b7h35xw 1ljg

30 Apr 19

Additional proxy soliciting materials

4:07pm